David Leslie Szekeres, Chief Business Officer & GC at Regulus, holds 0.00 shares in Regulus (Ticker: RGLS), holds 33.75K shares in Heron Therapeutics (Ticker: HRTX), holds ― shares in GRI Bio (Ticker: GRI). Most recently, David Leslie Szekeres ― shares of Regulus on ― for an estimated value of ―.